levodopa
UkraineDrugs containing this active substance
-
It is used for the treatment of Parkinson's disease and Parkinsonism syndrome to relieve symptoms such as muscle stiffness, slowed movements, tremor, swallowing difficulties, and postural instability.
Form: tablets
Active substance Dosage carbidopa 25 mg levodopa 250 mg ATC: N04BA02
-
The drug is used for the treatment of Parkinson's disease, specifically to alleviate motor impairments (instability) caused by the ineffectiveness of previous medication dosages.
Form: tablets, film-coated
Active substance Dosage levodopa 50 mg carbidopa 12.5 mg entacapone 200 mg ATC: N04BA03
Manufacturer: Orion Corporation
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from the ineffectiveness of previous levodopa dosing with dopa-decarboxylase inhibitors.
Form: tablets, film-coated
Active substance Dosage levodopa 100 mg carbidopa 25 mg entacapone 200 mg ATC: N04BA03
Manufacturer: Orion Corporation
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) that arise due to ineffective dosing during levodopa treatment with dopamine decarboxylase inhibitors.
Form: tablets, film-coated
Active substance Dosage levodopa 150 mg carbidopa 37.5 mg entacapone 200 mg ATC: N04BA03
Manufacturer: Orion Corporation
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from ineffective levodopa dosing with dopamine decarboxylase inhibitors.
Form: tablets, film-coated
Active substance Dosage levodopa 200 mg carbidopa 50 mg entacapone 200 mg ATC: N04BA03
Manufacturer: Orion Corporation
-
It is used for the treatment of Parkinson's disease and Parkinsonism.
Form: tablets
Active substance Dosage levodopa 250 mg carbidopa 25 mg ATC: N04BA02
Manufacturer: Farmas Start LLC
-
The drug is prescribed as adjunctive therapy for Parkinson's disease in patients who experience motor fluctuations during treatment with standard levodopa preparations.
Form: tablets, film-coated, prolonged release
Active substance Dosage levodopa 200 mg carbidopa 50 mg ATC: N04BA02
Manufacturer: Farmas Start LLC
-
The drug is used as add-on therapy for Parkinson's disease when standard immediate-release medications do not fully control motor disturbances (motor fluctuations).
Form: tablets, extended-release
Active substance Dosage levodopa 100 mg carbidopa 25 mg ATC: N04BA02
-
The drug is used as adjunctive therapy in Parkinson's disease, especially when standard medications cause motor fluctuations. It can also be used as an alternative to standard levodopa preparations with decarboxylase inhibitors.
Form: tablets, extended-release
Active substance Dosage levodopa 200 mg carbidopa 50 mg ATC: N04BA02
-
The drug is used for the treatment of all forms of parkinsonism (except drug-induced parkinsonism), as well as for the treatment of idiopathic and symptomatic restless legs syndrome.
Form: tablets
Active substance Dosage levodopa 200 mg benserazide 50 mg ATC: N04BA02
-
It is used for the treatment of Parkinson's disease and Parkinsonism.
Form: tablets
Active substance Dosage levodopa 250 mg carbidopa 25 mg ATC: N04BA02
Manufacturer: Lek Pharmaceuticals d.d. (batch control (only microbiological), batch release; primary and secondary packaging, batch release)